Publication Type:

Journal Article

Source:

Future Journal of Pharmaceutical Sciences, Volume 7, Issue 1, p.13 (2021)

URL:

https://doi.org/10.1186/s43094-020-00171-6

Abstract:

The nasal carriage of SARS-CoV-2 has been reported as the key factor transmitting COVID-19. Interventions that can reduce viral shedding from the nasopharynx could potentially mitigate the severity of the disease and its contagiousness. Herbal formulation of Citrus medica and Zingiber officinale is recommended in an Ayurvedic text as a nasal rinse in the management of contagious fevers. These herbs are also indicated in the management of respiratory illnesses and have been attributed with activity against pathogenic organisms in other texts. Molecular docking studies of the phytocompounds of C. medica and Z. officinale were done to find out whether these compounds could inhibit the receptor binding of SARS-CoV-2 spike protein (S protein) as well as the angiotensin-converting enzyme 2 (ACE-2), as evidenced from their docking into binding/active sites.

Cite this Research Publication

M. Haridas, Sasidhar, V., Nath, P., Abhithaj, J., Sabu, A., and Ram Manohar P., “Compounds of Citrus medica and Zingiber officinale for COVID-19 inhibition: in silico evidence for cues from Ayurveda”, Future Journal of Pharmaceutical Sciences, vol. 7, no. 1, p. 13, 2021.